References
- Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
- Julia F, Petrella T, Beylot-Barry M, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol 2013;169:579–586.
- Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms):a review. Am J Clin Pathol 2005;123:662–675.
- Pagano L, Valentini CG, Pulsoni A, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicentre study. Haematologica 2013;98:239–246.
- Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002;99:1556–1563.
- Montes-Moreno S, Ramos-Medina R, Martinez-Lopez A, et al. SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasm: characterisation of its expression in major haematolymphoid neoplasms. Blood 2013;121:643–647.
- Marafioti T, Paterson JC, Ballabio E, et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008;111:3778–3792.
- Scalvenzi M, Lucia G, Palmisano F, et al. Blastic plasmacytoid dendritic cell neoplasm: report of a case. J Clin Exp Dermatol Res 2012;S6:1.
- Leroux D, Mugneret F, Callanan M, et al. CD4(+), Cd56(+) DC2 acute leukaemia is characterised by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by Groupe Francais de Cytogenetique Hematologique. Blood 2002;99: 4154–4159.
- Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children:Diagnostic features and clinical implications. Haematologica 2010;95:1873–1879.
- Tsagarakis NK, Kentrou NA, Papdimitrious KA, et al. Acute lymphoplasmacytoid dendritic cell (DC2) leukaemia: results of the Hellenic Dendritic Cell Leukaemia Study Group. Leuk Res 2010;34: 438–446.
- Dalle S, Beylot-Barry M, Bagot M, et al. Plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?Br J Dermatol 2010;162:74–79.
- Hashikawa K, Niino D, Yasumoto S, et al. Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm. J Am Acad Dermatol 2012;66:278–291.
- Dietrich S, Andrulis M, Hegenbart U, et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant 2011;17:1250–1254.
- Roos-Weil D, Dietrich S, Boumendil A, et al. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood 2013;121:440–446.